Principal Scientist, Translational Sciences (Oncology)
Repertoire Immune Medicines
Summary
We are seeking a highly motivated and experienced professional in Translational Sciences that will be responsible for developing, implementing, and executing cross-functional activities to bridge preclinical and clinical development programs, across multiple therapeutic areas and drug modalities. A successful candidate will have a deep knowledge and focus on protein therapeutics, immune-oncology drug development, and genomic capabilities. Reporting to the Vice President, Project Lead and Head of Translational Medicine, this accomplished individual will have deep expertise in biomarkers in oncology to lead the design, implementation, and oversight of biomarker strategies for Phase I clinical trials in solid tumors. The ideal candidate will have a strong background in circulating tumor DNA (ctDNA), genomic profiling, and immune/DNA-based assays, as well as hands-on experience managing biomarker vendors and ensuring high-quality execution of exploratory biomarker analyses.
Job description
Role Overview
We are seeking a highly motivated and experienced professional in Translational Sciences that will be responsible for developing, implementing, and executing cross-functional activities to bridge preclinical and clinical development programs, across multiple therapeutic areas and drug modalities. A successful candidate will have a deep knowledge and focus on protein therapeutics, immune-oncology drug development, and genomic capabilities. Reporting to the Vice President, Project Lead and Head of Translational Medicine, this accomplished individual will have deep expertise in biomarkers in oncology to lead the design, implementation, and oversight of biomarker strategies for Phase I clinical trials in solid tumors. The ideal candidate will have a strong background in circulating tumor DNA (ctDNA), genomic profiling, and immune/DNA-based assays, as well as hands-on experience managing biomarker vendors and ensuring high-quality execution of exploratory biomarker analyses.
Key Responsibilities
- Design and execute translational biomarker strategies to support mechanism-of-action, PK/PD, dose predictions, and patient stratification in Phase I/II first-in-human oncology trials.
- Integrate preclinical and clinical data to generate hypotheses and guide data-driven decision-making in early development.
- Lead development and implementation of exploratory and translational biomarkers, including immune profiling, ctDNA, and genomic assays, with a strong understanding of solid tumor biology.
- Evaluate and oversee protein biomarker assays relevant to therapeutic response and resistance.
- Manage external vendors and CROs for biomarker assay development, sample testing, and data delivery; ensure high-quality execution and troubleshooting as needed.
- Oversee sample logistics (tumor tissue, liquid biopsies) to ensure integrity and timely analysis.
- Partner closely with Clinical Development and Discovery Research teams to ensure translational plans align with clinical objectives and regulatory strategies.
- Work closely with leadership to develop, manage, and deliver translational research timelines, budgets, metrics, and milestones.
- Demonstrate a strong work ethic and ability to work well in team environment.
- Communicate key findings and recommendations to senior leadership.
Qualifications
- PhD, MD, or equivalent in cancer biology, oncology, immunology, molecular biology, or related field.
- 8+ years of biotech/pharma experience in translational sciences or biomarker research, ideally in a biotech or pharmaceutical environment.
- Deep understanding of solid tumor biology, immune biomarkers, and ctDNA/genomic analysis, along with hands-on experience managing biomarker execution in early-phase clinical trials.
- Strong understanding of drug development for protein therapeutics and immune-oncology mechanisms.
- Demonstrated experience supporting Phase I/II first-in-patient clinical studies.
- Experience incorporating ctDNA endpoints into Phase I/II oncology clinical trials, including exploratory biomarker strategies and regulatory considerations.
- Experience transferring and overseeing assays at CROs or central labs.
- Working knowledge of pharmacokinetics (PK) and anti-drug antibody (ADA) assessments for protein therapeutics, and ability to integrate PK/ADA findings with biomarker and clinical data to guide early development decisions.
- Hands-on or oversight experience with circulating tumor DNA (ctDNA), including use in solid tumor clinical trials for patient stratification and treatment response monitoring.
- Entrepreneurial mindset, excellent communication skills, and passion for advancing new therapies for patients.
Requirements
- PhD, MD, or equivalent in cancer biology, oncology, immunology, molecular biology, or related field
- 8+ years of biotech/pharma experience in translational sciences or biomarker research
- Deep understanding of solid tumor biology, immune biomarkers, and ctDNA/genomic analysis
- Hands-on experience managing biomarker execution in early-phase clinical trials
- Strong understanding of drug development for protein therapeutics and immune-oncology mechanisms
- Demonstrated experience supporting Phase I/II first-in-patient clinical studies
- Experience incorporating ctDNA endpoints into Phase I/II oncology clinical trials
- Experience transferring and overseeing assays at CROs or central labs
- Working knowledge of pharmacokinetics (PK) and anti-drug antibody (ADA) assessments
- Hands-on or oversight experience with circulating tumor DNA (ctDNA)
- Entrepreneurial mindset
- Excellent communication skills
Benefits
- Medical, Dental & Vision
- Life Insurance
- Flexible Time Off
- 401(k) Retirement Plan
- Short-term Incentive
- Long-term Incentive
Company overview
Repertoire Immune Medicines is a biotechnology company pioneering the development of novel immune-based therapeutics through its proprietary DECODE platform. The company focuses on discovering and developing T-cell receptor (TCR)-based medicines for cancer and autoimmune diseases. By leveraging advanced computational biology and high-throughput sequencing technologies, Repertoire aims to map the complete repertoire of T-cell receptors and identify disease-specific targets. The company's innovative approach combines immunology expertise with machine learning to decode the immune system's language and develop precision immunotherapies. Based in Cambridge, Massachusetts, Repertoire Immune Medicines represents a cutting-edge convergence of immunology, genomics, and computational science to create transformative treatments for patients with serious diseases.